Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →Short answer: “Regenerative medicine” is not a single treatment. In the United States, FDA approval applies to a particular product for a particular condition—not to every use a clinic associates with the words stem cell, exosome, cord blood, or regenerative. FDA says the approved stem-cell products covered by its consumer alert are blood-forming cells from umbilical cord blood for disorders affecting blood production. Other regenerative products, including certain engineered tissues, cell therapies, and gene therapies, have narrow, product-specific indications. Many heavily advertised uses—such as injections for arthritis, back pain, neurologic disease, chronic pain, autism, or fatigue—are not FDA-approved stem-cell uses.
The safest way to evaluate an offer is to identify the exact product and indication, verify the regulator’s record, distinguish an approved treatment from an investigational trial, and review risks and follow-up with the relevant specialist.
As an Amazon Associate I earn from qualifying purchases.
What “regenerative medicine” includes
FDA defines regenerative medicine as an approach intended to restore, replace, or recreate cells, tissues, or organs to treat or mitigate disease. The category includes cell therapies, therapeutic tissue engineering, combination products, some gene therapies, and human cell and tissue products. These modalities differ in how they are made, delivered, monitored, and regulated.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
That breadth is why a field label is not enough to judge a treatment. “Stem cell therapy” might refer to hematopoietic progenitor cells used in blood disorders, an experimental cell preparation in a clinical trial, or an unapproved commercial injection. The cell source, manufacturing process, dose, route, target condition, and eligibility criteria all affect whether evidence applies to a particular patient.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
The International Society for Stem Cell Research (ISSCR) puts the distinction plainly: “Stem cell treatments are not one-size-fits-all.” A result for one cell type or disease cannot be transferred automatically to a different condition.
What is FDA-approved in the United States?
Approval is tied to the named product, labeled indication, manufacturing controls, and the patients described in that label. It does not authorize a clinic to promote the same product for unrelated diseases.
| Example or category | What the federal record establishes | What it does not establish |
|---|---|---|
| Hematopoietic progenitor cells from umbilical cord blood | FDA’s consumer alert identifies these as the approved stem-cell products covered by the alert, for disorders affecting blood production. | Approval for arthritis, pain, neurologic disease, anti-aging, or other conditions. |
| Zevaskyn | Listed by FDA’s CBER Regenerative Medicine Advanced Therapy (RMAT) approvals as a product for wounds associated with recessive dystrophic epidermolysis bullosa. | A general wound-healing or cosmetic indication, or use in people who do not meet the product’s eligibility requirements. |
| Symvess | Listed in the RMAT approvals as a vascular-conduit use after specified extremity arterial injuries when an autologous vein graft is not feasible. | Routine treatment for every vascular condition or a substitute for the labeled surgical circumstances. |
| Other cell and gene therapies | FDA’s RMAT list, dated “Data as of September 30, 2025,” includes products for specific cancers and inherited conditions. | A broad license to market those products for wellness, unrelated diseases, or general tissue repair. |
The RMAT designation or listing is not itself a universal endorsement of regenerative medicine. Patients must check the current FDA label and whether their diagnosis, disease stage, prior treatment, age, and other criteria match it. If a clinic cannot provide the exact product name and approved indication, you cannot assume the treatment is approved.
Free tools Windows power users keep installed
One-click scans. No signup required.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Uses FDA says are not approved for the stem-cell products in its consumer alert
FDA’s July 22, 2020 consumer alert says the stem-cell products addressed there are not approved for the following uses:
- Orthopedic conditions, including osteoarthritis, tendonitis, disc disease, tennis elbow, and back, hip, knee, neck, or shoulder pain.
- Neurologic disorders, including multiple sclerosis, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Parkinson’s disease, epilepsy, and stroke.
- Cardiovascular or pulmonary disease.
- Autism.
- Macular degeneration or blindness.
- Chronic pain or fatigue.
The same alert says there are no FDA-approved exosome products. This status statement concerns the product classes and uses described by FDA in the United States. It does not mean legitimate scientific work has stopped, and it does not turn participation in a trial into proof that a treatment works.
A clinic’s statement that its product “treats” a condition is therefore only a marketing claim until the exact product and indication can be matched to a regulator’s approval record. A different country may have different rules; ask which jurisdiction issued the authorization and whether that authorization covers your condition.
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Why a clinical trial is not the same as an approved treatment
A clinical trial tests a hypothesis under a protocol. Investigators may be studying safety, dosing, immune reactions, durability, or a possible benefit that has not yet been demonstrated. Trials can show that a treatment is ineffective or unsafe, and many candidates never reach approval.
For a U.S. investigational product, ask whether the study is conducted under an FDA-issued Investigational New Drug (IND) authorization when one is required. Request the trial identifier, the consent form, the sponsor’s contact information, and a plain-language explanation of monitoring and follow-up. An entry on ClinicalTrials.gov is useful for locating a study, but a listing alone does not prove that FDA has approved the product or that it may be sold.
Likewise, a company’s FDA registration or listing is not marketing approval. Registration identifies a facility or business in a regulatory system; it does not verify the quality, safety, potency, or effectiveness of every product that business offers.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
ISSCR summarizes the evidence threshold this way: “Stem cell treatments must be evaluated for efficacy and safety in regulated clinical trials before they receive approval.”
A practical verification process before you agree to treatment
- Write down the exact intervention. Get the product’s full name, cell or gene type, source tissue, dose, route of administration, and whether it is manipulated or combined with another device or drug. “Your own cells,” “umbilical,” “placental,” “exosome,” and “regenerative” are descriptions, not sufficient product identities.
- Define the intended use. Ask the clinician to state the diagnosis and treatment goal in writing. Confirm whether the proposed use is on the product’s FDA label or is investigational. Approval for one condition does not carry over to another.
- Verify the regulator’s record yourself. Use FDA’s product labeling and approval databases, and ask which federal or state authority granted authorization. If the provider cites an RMAT designation, clarify that RMAT is a regulatory pathway and designation, not a blanket approval for all uses.
- If it is a trial, obtain the protocol details. Request the ClinicalTrials.gov identifier, the IND information supplied to participants when applicable, eligibility criteria, randomization or control procedures, visit schedule, laboratory monitoring, and the plan for long-term follow-up.
- Examine human evidence for this exact product and condition. Look for controlled human data rather than testimonials, before-and-after photographs, animal studies, or results from a different cell type. Ask how outcomes were measured, how long patients were followed, and what adverse events occurred. If no controlled evidence is available, treat the claimed benefit as unproven.
- Compare alternatives. Ask your treating specialist what standard treatments are available, what their expected benefits and risks are, and what could be lost by delaying them. A proposed injection should not quietly replace a therapy with established benefit.
- Clarify cost and responsibility. Determine every charge, whether insurance pays, who owns the product, who handles complications, and where emergency care would occur. Paying a clinic does not make an investigational intervention an approved treatment.
- Get an independent opinion. Bring the consent form, product information, and protocol to a physician who is not financially involved in the clinic. A specialist familiar with your diagnosis can judge whether the proposed biology and risk are plausible for your case.
Potential harms and why manufacturing matters
FDA warns that illegally marketed regenerative products can cause serious harm. Possible problems include:
PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware match- Blindness or other vision loss.
- Tumor formation or unwanted cell growth.
- Neurologic events.
- Bacterial infection, including life-threatening bloodstream infection.
- Severe reactions at the collection or injection site.
- Unwanted inflammatory or immune responses.
- Cells migrating to, or growing in, unintended tissues.
- Contamination during collection, processing, storage, or administration.
- Failure to work while an effective approved treatment is delayed or abandoned.
These hazards do not occur at the same frequency in every therapy. Risk depends on the product, processing, route, sterility controls, patient’s immune status, and the quality of clinical monitoring. A laboratory label or a claim that cells are “natural” does not remove those risks.
Best Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
In a 2025 warning about unapproved human-cell and human-tissue products marketed online, FDA described adverse-event reports that included deaths. The warning discussed a reported death involving an imported placental-tissue product called Laennec. FDA said direct testing of the product administered to that patient was not feasible, and testing of remaining samples did not isolate the pathogen associated with the death. That account should not be rewritten as proof that the product caused the death or that a pathogen was found in the administered dose. FDA’s broader point was that the products had not undergone verified review of quality, safety, purity, or potency.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Warning signs of an unsafe or misleading offer
- One product for many unrelated diseases: ISSCR cautions against clinics presenting one stem-cell treatment as suitable for conditions affecting different organs and biological systems.
- Testimonials instead of controlled evidence: Individual stories cannot show how many people failed to improve, how outcomes were measured, or whether improvement came from another treatment.
- Pressure to pay immediately: High fees, time-limited discounts, or demands for travel before you receive a complete consent document are reasons to pause.
- Vague product language: Refusal to identify the cell source, handling process, dose, or responsible manufacturer prevents meaningful safety evaluation.
- Regulatory name-dropping: “FDA registered,” “FDA listed,” RMAT designation, or a ClinicalTrials.gov page is presented as if it were product approval.
- No plan for complications: A legitimate study or treatment should identify emergency contacts, adverse-event reporting, monitoring visits, and long-term follow-up.
- Promises of certainty: Claims of guaranteed regeneration, a cure, or no side effects are inconsistent with responsible clinical evidence.
How to compare an approved treatment, a trial, and a commercial clinic offer
| Question | FDA-approved treatment | Authorized clinical trial | Unverified commercial offer |
|---|---|---|---|
| What is authorized? | A named product for a labeled condition and eligible population. | A protocol to investigate a product or use; effectiveness may be unknown. | Often only a business or facility registration, not authorization to market the treatment. |
| Evidence expectation | FDA has reviewed evidence required for the approval pathway. | Evidence is being collected; results may be positive, negative, or inconclusive. | May rely mainly on testimonials, uncontrolled case series, or claims that cannot be independently verified. |
| Patient protections | Labeling, manufacturing requirements, and post-market safety obligations apply. | Informed consent, protocol oversight, eligibility rules, and specified monitoring should apply. | Protections and accountability may be unclear; quality and potency may not have been verified. |
| Payment | Coverage depends on the product and insurance policy. | Ask which procedures are covered by the study and which costs the participant must pay. | A fee does not establish approval, effectiveness, or legal marketing status. |
When a comparison cell cannot be answered by the provider or a regulator’s record, treat that missing information as a decision-relevant risk rather than filling the gap with assumptions.
Questions to take to your doctor or study team
- What is the exact product, source, cell or gene type, and manufacturing process?
- What specific diagnosis and eligibility criteria does it address?
- Is it approved for me, or is it investigational?
- Which regulator authorized it, and where can I read the current label or protocol?
- If it is investigational, what is the trial identifier and what FDA-issued IND information is available to participants?
- What controlled human evidence supports this exact product and use?
- What benefits are realistic, and what remains uncertain?
- What short- and long-term risks have been observed or are biologically plausible?
- What standard alternatives exist, and what happens if I decline or delay this option?
- Who reports adverse events, who pays for complication care, and how long will follow-up continue?
What to do if something goes wrong
Seek urgent medical care for symptoms such as sudden vision changes, weakness, confusion, severe headache, high fever, spreading redness, breathing difficulty, chest pain, or signs of a serious allergic reaction after a cell or tissue procedure. Tell the emergency team exactly what was administered, when, where, and by whom; bring the consent form, product label, and lot information if available.
Patients and clinicians can report suspected adverse events to FDA MedWatch. Keep copies of invoices, treatment records, laboratory results, consent documents, and advertising. These records help your treating physician and regulators determine what product was used and whether other patients may be at risk.
Bottom line for a treatment decision
Regenerative medicine can be legitimate, but legitimacy belongs to a specific product, indication, manufacturing process, and evidence base. In the United States, FDA’s approved stem-cell products identified in its consumer alert are cord-blood blood-forming cells for blood-production disorders; other regenerative products have narrowly defined approvals such as those listed for Zevaskyn, Symvess, and certain cell or gene therapies. Most clinic promises involving orthopedic pain, neurologic disease, chronic pain, autism, fatigue, or exosomes are not approvals for those uses. Verify the product and indication, distinguish a regulated trial from a marketed treatment, insist on a complication and follow-up plan, and involve the specialist who manages your condition before proceeding.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
